TITLE

Once-daily Tadalafil for ED: Efficacy and Safety

AUTHOR(S)
Kuritzky, Louis
PUB. DATE
August 2013
SOURCE
Internal Medicine Alert;8/15/2013, Vol. 35 Issue 15, p119
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents brief information on a study led by A.D. Seftel and colleagues on the therapeutic use of Tadalafil (TAD-QD) among men with erectile dysfunction.
ACCESSION #
90172371

 

Related Articles

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // Clinical Oncology Alert;Sep2013 Clincal Briefs, p17 

    The article discusses the study of A. D. Seftel and colleagues regarding the efficacy and safety of daily doses of tadalafil (TAD-QD) in men who suffer from mild-moderate erectile dysfunction (ED).

  • Once-daily Tadalafil for ED: Efficacy and Safety. Kuritzky, Louis // Clinical Cardiology Alert;Sep2013 Clinical Briefs, p17 

    The article discusses the study of A. D. Seftel and colleagues regarding the efficacy and safety of taking 2.5-10.0 milligrams per day of tadalafil (TAD-QD) for men who suffer from erectile dysfunction (ED).

  • Efficacy of Tadalafil De-Escalation in the Treatment of Psychogenic Erectile Dysfunction. Li, Guangyu; Lan, Haiyan; Liang, Jihong; Zhang, Chengmei; Huang, Cunchao // Urologia Internationalis;Mar2017, Vol. 98 Issue 2, p205 

    Objectives: To assess the efficacy of tadalafil de-escalation in the therapeutic effects of psychogenic erectile dysfunction (ED) during the 3 months extension phase. Methods: A total of 90 men with mild to severe psychogenic ED were randomly divided into 2 groups: tadalafil 5 mg group and...

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // Infectious Disease Alert;Sep2013 Clinical Briefs, p17 

    The article discusses research done on the efficacy and safety of once-daily tadalafil for erectile dysfunction by A. D. Seftel, published in the 2013 issue of the "International Journal of Impotence Research."

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // Neurology Alert;Sep2013 Clinical Briefs, p17 

    The article discusses research on the efficacy and safety of tadalafil in restoring sexual function in men, which was conducted by A.D. Seftel and colleagues and published in the 2013 issue of the "International Journal of Impotence Research."

  • Tadalafil.  // Reactions Weekly;9/7/2013, Issue 1468, p36 

    The article presents a case study of a 23-year-old man who developed tonic-clonic seizures while being treated with tadalafil for erectile dysfunction.

  • Once-daily Tadalafil for ED: Efficacy and Safety.  // OB/GYN Clinical Alert;Sep2013 Clincal Briefs, p17 

    The article focuses on a study related to the safety and efficacy of once daily tadalafil (TAD-QD) in doses ranging from 2.5-10.0 miligram per day and also highlights that TAD-QD has more than doubled the rates of successful intercourse.

  • Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily. Iacono, Fabrizio; Prezioso, Domenico; Illiano, Ester; Romeo, Giuseppe; RuffoQ, Antonio; Amato, Bruno // BMC Surgery;2012, Vol. 12 Issue Suppl 1, p1 

    Background: Reduced libido is widely considered the most prominent symptomatic reflection of low testosterone (T) levels in men. Testosterone deficiency (TD) afflicts approximately 30% of men aged 40-79 years. This study seeks to evaluate the effect of a new natural compound "tradamixina "in...

  • Outcome following surgery. Fawcett, W. // Anaesthesia;Sep2019, Vol. 74 Issue 9, p1204 

    I congratulate Drs Shah and Bailey on their excellent editorial [1], steering us away from the traditional yet unreliable metrics of outcome - such as hospital length of stay (LOS) and mortality. 7 Gustafsson UO, Oppelstrup H, Thorell A, Nygren J, Ljungqvist O. Adherence to the ERAS protocol is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics